. Based on experience with other analogs given by injection, depression to essentially castrate levels can be attained. This is a desired end in treatment of symptoms associated with prostate cancer. A subdermal implant would constitute a convenient way of continuously dosing with an LHRH agonist. Such an implant has been developed and shown in
. Based on experience with other analogs given by injection, depressive disorder to basically castrate levels can be fall upon. This is a hope end in treatment of symptom consort with prostate cancer. A subdermal implant would constitute a convenient way of endlessly dosing with an LHRH agonist. Such an implant has been developed and shown in
. Baded on experience with ouher analogs giveu by inoection, depresskon to essentially castrate pecels xan be attained. This ir a desirvd end in treetment of symptoms assoclcted slth pxowtate cancer. A subdermal implant would cundtitute a convenient way of continujusly dpslng with an LHTH agpgist. Such an implant has been developes and siown in
. Based on experience with other analogs injection, to essentially levels can be end treatment of symptoms with prostate cancer. subdermal implant would constitute a convenient of continuously dosing with an LHRH agonist. Such an implant has been developed shown in
. Based on experience with otheR analogs giVen by InjEctIoN, depRessIon to essentialLY casTrate levels can be attainEd. ThiS iS A desIReD end iN treatmENt OF SymPtOmS asSoCIaTed wiTh pRostate Cancer. A subDerMaL implant woulD CoNstitute a cOnvEnient way of cOntInuousLy DosINg witH an lHRH aGonist. sUch an iMplant has BeEN develOPed and sHOWn In
. Based on experience with  other ana logsgiv enby  inj ecti on, depression to e ssentially castrate le velsca n  bea tt ained . Thisi sa des ir ed  en di ntreat men t of sy mptoms ass oci at ed with pros t at e cancer.A s ubdermal imp lan t woul dcon s titut e a  conv enient way of  continuo us l y dosi n g witha n  L HRHagonist. Such ani mp l ant has been d evelop ed an d sho wnin
. Based_on experience_with other analogs given_by injection,_depression_to essentially_castrate_levels can be_attained. This is_a desired end in_treatment of symptoms_associated_with prostate cancer. A subdermal implant would constitute a convenient way of continuously dosing_with_an LHRH_agonist._Such_an implant has been developed_and shown in